These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38471833)

  • 1. Antithrombotic Therapy in Cerebral Cavernous Malformations: A Systematic Review, Meta-Analysis, and Network Meta-Analysis.
    Musmar B; Salim H; Abdelgadir J; Spellicy S; Adeeb N; Zomorodi A; Friedman A; Awad I; Jabbour PM; Hasan DM
    J Am Heart Assoc; 2024 Mar; 13(6):e032910. PubMed ID: 38471833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis.
    Zuurbier SM; Hickman CR; Tolias CS; Rinkel LA; Leyrer R; Flemming KD; Bervini D; Lanzino G; Wityk RJ; Schneble HM; Sure U; Al-Shahi Salman R;
    Lancet Neurol; 2019 Oct; 18(10):935-941. PubMed ID: 31401075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations.
    Schneble HM; Soumare A; Hervé D; Bresson D; Guichard JP; Riant F; Tournier-Lasserve E; Tzourio C; Chabriat H; Stapf C
    Stroke; 2012 Dec; 43(12):3196-9. PubMed ID: 23150651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To use or not to use antithrombotics in unruptured cerebrovascular malformations? A systematic review focusing on this clinical and surgical dilemma.
    Bianconi A; Ceraudo M; Nico E; Minardi M; Allevi M; Prior A; Garbossa D; Zona G; Fiaschi P
    Neurosurg Focus; 2023 Oct; 55(4):E14. PubMed ID: 37778036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Long-Term Antithrombotic and Statin Therapy on the Clinical Outcome in Patients with Cavernous Malformations of the Central Nervous System: A Single-Center Case Series of 428 Patients.
    Wildi S; Nager S; Akeret K; Özkaratufan S; Krayenbühl N; Bozinov O; Regli L; Velz J
    Cerebrovasc Dis; 2023; 52(6):634-642. PubMed ID: 36944322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female Hormone Therapy and Risk of Intracranial Hemorrhage From Cerebral Cavernous Malformations: A Multicenter Observational Cohort Study.
    Zuurbier SM; Santos AN; Flemming KD; Schmidt B; Jabbarli R; Lanzino G; Sure U; Dammann P
    Neurology; 2023 Apr; 100(16):e1673-e1679. PubMed ID: 36754635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding risk evaluation in cerebral cavernous malformation, the role of medications, and hemorrhagic factors: a case-control study.
    Scerrati A; Mantovani G; Travaglini F; Bradaschia L; De Bonis P; Farneti M; Cavallo MA; Dones F; Flacco ME; Auricchio AM; Benato A; Albanese A; Sturiale CL
    Neurosurg Focus; 2023 Oct; 55(4):E15. PubMed ID: 37778034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Beta-Blocker or Statin Drug Use and the Risk of Hemorrhage From Cerebral Cavernous Malformations.
    Zuurbier SM; Hickman CR; Rinkel LA; Berg R; Sure U; Al-Shahi Salman R;
    Stroke; 2022 Aug; 53(8):2521-2527. PubMed ID: 35410492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
    Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis.
    Nochaiwong S; Ruengorn C; Awiphan R; Chai-Adisaksopha C; Tantraworasin A; Phosuya C; Kanjanarat P; Chongruksut W; Sood MM; Thavorn K
    Ann Med; 2022 Dec; 54(1):80-97. PubMed ID: 34955074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of anticoagulant therapy re-initiation after gastrointestinal bleeding: A systematic review and meta-analysis.
    Bingzheng X; Jingnan R; Ligang B; Jianping C
    J Clin Pharm Ther; 2021 Dec; 46(6):1509-1518. PubMed ID: 34101229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of antithrombotic treatment on clinical outcomes after craniotomy for unruptured intracranial aneurysm.
    Nakamizo A; Michiwaki Y; Kawano Y; Amano T; Matsuo S; Fujioka Y; Tsumoto T; Yasaka M; Okada Y
    Clin Neurol Neurosurg; 2017 Oct; 161():93-97. PubMed ID: 28865323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antithrombotic agents in patients with intracerebral cavernous malformations.
    Flemming KD; Link MJ; Christianson TJ; Brown RD
    J Neurosurg; 2013 Jan; 118(1):43-6. PubMed ID: 22998055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding Risk of Cerebral Cavernous Malformations in Patients on Statin and Antiplatelet Medication: A Cohort Study.
    Marques LL; Jaeggi C; Branca M; Raabe A; Bervini D; Goldberg J
    Neurosurgery; 2023 Sep; 93(3):699-705. PubMed ID: 36999926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic treatment after stroke due to intracerebral haemorrhage.
    Cochrane A; Chen C; Stephen J; Rønning OM; Anderson CS; Hankey GJ; Al-Shahi Salman R
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012144. PubMed ID: 36700520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
    Ke Y; Wang J; Wang W; Guo S; Dai M; Wu L; Bao Y; Li B; Ju J; Xu H; Jin Y
    Int J Cardiol; 2022 Sep; 362():139-146. PubMed ID: 35654173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation.
    Lin SY; Chang YC; Lin FJ; Tang SC; Dong YH; Wang CC
    J Am Heart Assoc; 2022 Mar; 11(6):e022849. PubMed ID: 35243876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
    Kuno T; Takagi H; Sugiyama T; Ando T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Kanei Y; Hayashida K; Bangalore S
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E177-E186. PubMed ID: 31609071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intracranial hemorrhages: epidemiology and implication of antithrombotic therapy].
    Varvat J; Epinat M; Nuti C; Antoine JC; Mismetti P; Garnier P
    Therapie; 2013; 68(3):143-7. PubMed ID: 23886458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases.
    Savarese G; Reiner MF; Uijl A; D'Amario D; Agewall S; Atar D; Baumgartner I; Borghi C; De Carlo M; Drexel H; Kaski JC; Kjeldsen KP; Kucher N; Lund LH; Niessner A; Semb AG; Schmidt TA; Sulzgruber P; Tamargo J; Vitale C; Wassmann S; Aboyans V; Lewis BS
    Eur Heart J Cardiovasc Pharmacother; 2020 Apr; 6(2):86-93. PubMed ID: 31392312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.